Showing 241–256 of 414 resultsSorted by popularity
Semaglutide is a long-acting GLP-1 receptor agonist with a 168-hour half-life that stimulates glucose-dependent insulin secretion and centrally suppresses appetite. An oral formulation for investigating sustained incretin-mediated weight loss.
Stanolone (DHT) is the pure 5-alpha-reduced androgen that binds the nuclear androgen receptor with 3-10 times higher affinity than testosterone. It is structurally incapable of aromatization, providing pure androgenic signaling for research into DHT-specific pathways.
19-nor androgen for progestin activity and collagen research. Study joint recovery and anabolic pathways.
SLU-PP-332 is a first-in-class small molecule pan-agonist of Estrogen-Related Receptors (alpha, beta, gamma) that mimics exercise-induced metabolic adaptations. It drives mitochondrial biogenesis and fatty acid oxidation without physical exertion, serving as a top-tier exercise mimetic research tool.
Finasteride is a selective Type II 5-alpha-reductase inhibitor that competitively blocks testosterone-to-DHT conversion, reducing serum DHT by approximately 70%. A targeted research tool for investigating androgen-dependent hair follicle preservation.
Dianabol (Methandienone) is a potent C17-alpha-alkylated testosterone derivative featuring a delta-1 double bond for enhanced anabolic activity. It drives rapid myofibrillar protein synthesis and positive nitrogen balance, rendering it a core oral androgen for muscle growth research.
Supertest 450 is an ultra-high-concentration multi-ester testosterone blend at 450mg/ml combining Enanthate, Cypionate, and Decanoate esters. Staggered ester cleavage provides both rapid onset and extended sustained release for maximal androgenic synergy.
Winstrol (Stanozolol) 100mg/ml Injectable is a high-concentration pyrazole-modified DHT derivative that inhibits SHBG synthesis and binds microsomal androgen receptors. The oil-based delivery provides a 24-hour half-life with superior bioavailability.
BLEND-500 TRE DE Live Blend Oil Steroids Injectable for research use.
SLU-PP-332 is a first-in-class pan-agonist of Estrogen-Related Receptors (alpha, beta, gamma) that recruits PGC-1alpha to upregulate mitochondrial oxidative phosphorylation. An oral exercise mimetic for investigating metabolic adaptation without physical exertion.
GW-501516 (Cardarine) is a high-affinity PPAR-delta agonist that recruits PGC-1alpha co-activators to upregulate fatty acid oxidation, mitochondrial biogenesis, and Type I oxidative fiber conversion. An excellent endurance-enhancing research compound.
Anadrol (Oxymetholone) is a potent C17-alpha-alkylated DHT derivative that uniquely stimulates erythropoietin secretion alongside androgen receptor activation, driving both red blood cell expansion and myofibrillar protein synthesis.
Masteron (Drostanolone Propionate) is a short-acting DHT derivative with a 2-3 day half-life that provides rapid androgen receptor saturation. The 2-methyl modification inhibits 3-alpha-HSD deactivation, ensuring sustained bioactivity within skeletal muscle.
Equipoise (Boldenone Undecylenate) is a long-acting injectable androgen with a 14-day half-life that stimulates erythropoietin production for increased red blood cell mass and drives lean tissue accrual through sustained androgen receptor activation. Its low SHBG affinity ensures high bioavailability.
End of content
End of content
No products in the cart.
